There are two primary things that have prompted me to develop my current approach to MCAS. First being that most of my clients who have MCAS or histamine intolerance are on the more severe end of the spectrum. Second, a bias I’ve developed from my own experience with MCAS (and seeing others in the same boat) wherein I did not respond to conventional nor integrative medicine approaches to MCAS.

This is an overview of Part 1 + 2 of Dr. Code and Kristina Mitts’ Facebook Live series on Coronavirus and the microbiome. To get all the details make sure you watch the replay, but if you lack the time here are the main points.

This is an overview of Part 1 + 2 of Dr. Code and Kristina Mitts’ Facebook Live series on Coronavirus and the microbiome. To get all the details make sure you watch the replay, but if you lack the time here are the main points. Studies out of China have revealed characteristic imbalances occurring within the gut and lung microbiomes of COVID-19 patients making them more susceptible to fatality. These differences happen to correlate with the higher risk groups; Diabetes, CVD, cancer and aging. Evidently, this is one aspect of our health that, if imbalanced, will promote disease progression of the Corona Virus.

G6PD deficiency is a genetic condition which leads to a lack of the G6PD (glucose-6-phosphate dehydrogenase) enzyme. This molecule generates NADPH production in red blood cells and protects them from damage by oxidative stress.